Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Assets Average (2016 - 2025)

Lipocine's Assets Average history spans 13 years, with the latest figure at $17.3 million for Q3 2025.

  • For Q3 2025, Assets Average fell 20.76% year-over-year to $17.3 million; the TTM value through Sep 2025 reached $17.3 million, down 20.76%, while the annual FY2024 figure was $22.8 million, 24.83% down from the prior year.
  • Assets Average reached $17.3 million in Q3 2025 per LPCN's latest filing, down from $19.5 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $50.0 million in Q1 2022 to a low of $17.3 million in Q3 2025.
  • Average Assets Average over 5 years is $32.7 million, with a median of $32.3 million recorded in 2023.
  • Peak YoY movement for Assets Average: soared 119.79% in 2021, then crashed 37.96% in 2023.
  • A 5-year view of Assets Average shows it stood at $46.4 million in 2021, then dropped by 17.13% to $38.5 million in 2022, then plummeted by 37.96% to $23.9 million in 2023, then dropped by 9.52% to $21.6 million in 2024, then dropped by 19.81% to $17.3 million in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Assets Average are $17.3 million (Q3 2025), $19.5 million (Q2 2025), and $21.5 million (Q1 2025).